ClinicalTrials.Veeva

Menu

A Clinical Trial Study to Evaluate Efficacy and Safety of Atorvastatin in Korean Patients With Hypercholesterolemia

Yonsei University logo

Yonsei University

Status and phase

Completed
Phase 4

Conditions

Hypercholesterolemia

Treatments

Drug: atorvastatin

Study type

Interventional

Funder types

Other

Identifiers

NCT01081548
4-2008-0288

Details and patient eligibility

About

The purpose of this study is to compare the efficacy and safety of atorvastatin generic product with reference drug.

Enrollment

17 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Age 20 ~ 79
  • People who have not reached LDL-C targeted level in accordance with the guidelines for hyperlipidemia management released by Korean Society of Lipidology and Atherosclerosis
  • In case of female participants taking combination HRT or oral contraceptive, they should maintain stable capacity and usage at least for 8 weeks before the visit 1.

Trial design

17 participants in 2 patient groups

Generic
Experimental group
Treatment:
Drug: atorvastatin
Drug: atorvastatin
Lipitor
Active Comparator group
Treatment:
Drug: atorvastatin
Drug: atorvastatin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems